InvestSMART

Cochlear Limited (ASX: COH) - Announcements

Current share price for COH : $144.360 0.77 (0.53%)+

ASX company news and announcements for Cochlear Limited (COH) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Cochlear Limited (COH) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Cochlear Limited (COH), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Cochlear Limited (COH)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$9,441 Resignation of CFO 13 Jul 2020 9:04AM $190.470 $144.360 fallen by 24.21%
$9,441 Cochlear advises of FDA approval for four new products 3 Jul 2020 8:29AM $192.690 $144.360 fallen by 25.08%
$9,441 Appendix 3Y - Bruce Robinson 29 Jun 2020 9:45AM $189.660 $144.360 fallen by 23.88%
$9,441 Denial of appeal rehearing in US patent infringement case 19 May 2020 9:50AM $189.010 $144.360 fallen by 23.62%
$9,441 Confirmation of COVID-19 pandemic impact on trading 11 May 2020 8:35AM $181.660 $144.360 fallen by 20.53%
$9,441 Appendix 3Y - Donal O'Dwyer 6 May 2020 3:20PM $181.940 $144.360 fallen by 20.66%
$9,441 Appendix 3Y - Andrew Denver 6 May 2020 9:13AM $182.000 $144.360 fallen by 20.68%
$9,441 Appendix 3Y - Bruce Robinson 5 May 2020 10:17AM $181.670 $144.360 fallen by 20.54%
$9,441 Appendix 3Y - Yasmin Allen 5 May 2020 10:14AM $181.670 $144.360 fallen by 20.54%
$9,441 Appendix 3Y - Abbas Hussain 4 May 2020 9:13AM $179.950 $144.360 fallen by 19.78%
$9,441 Appendix 3Y - Rick Holliday-Smith 4 May 2020 9:01AM $179.950 $144.360 fallen by 19.78%
$9,441 Appendix 3Y - Michael Daniell 4 May 2020 8:59AM $179.950 $144.360 fallen by 19.78%
$9,441 Appendix 3Y - Glen Boreham 4 May 2020 8:59AM $179.950 $144.360 fallen by 19.78%
$9,441 Appendix 3Y - Diggory Howitt 4 May 2020 8:58AM $179.950 $144.360 fallen by 19.78%
$9,441 Appendix 3Y - Alison Deans 4 May 2020 8:57AM $179.950 $144.360 fallen by 19.78%
$9,441 Change in substantial holding 1 May 2020 8:14AM $184.500 $144.360 fallen by 21.76%
$9,441 Appendix 2A 30 Apr 2020 10:21AM $184.720 $144.360 fallen by 21.85%
$9,441 Cochlear Completes Share Purchase Plan 28 Apr 2020 4:20PM $185.920 $144.360 fallen by 22.35%
$9,441 Cochlear receives expedited FDA approval of Remote Check 8 Apr 2020 10:20AM $182.110 $144.360 fallen by 20.73%
$9,441 Temporary pay reduction for Board, CEO & senior executives 7 Apr 2020 9:23AM $191.370 $144.360 fallen by 24.56%
$9,441 Becoming a substantial holder 2 Apr 2020 4:53PM $190.000 $144.360 fallen by 24.02%
$9,441 Cochlear Share Purchase Plan Offer Open 1 Apr 2020 9:36AM $187.450 $144.360 fallen by 22.99%
$9,441 Cleansing Notice under Section 708A(5)(e) of the Corporation 31 Mar 2020 9:38AM $182.810 $144.360 fallen by 21.03%
$9,441 Appendix 2A 30 Mar 2020 9:59AM $166.470 $144.360 fallen by 13.28%
$9,441 Appendix 3B - Update to Proposed Issue of Securities - COH 27 Mar 2020 2:29PM $170.540 $144.360 fallen by 15.35%

576 - 600 of 939 results

Page 24 of 38

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.